N 943 (Dextroamphetamine Sulfate Extended-Release 5 mg)
Pill with imprint N 943 is Brown, Capsule-shape and has been identified as Dextroamphetamine Sulfate Extended-Release 5 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Dextroamphetamine is used in the treatment of adhd; narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for N 943
Dextroamphetamine Sulfate Extended-Release
- Imprint
- N 943
- Strength
- 5 mg
- Color
- Brown
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- National Drug Code (NDC)
- 68382-0943
- Inactive Ingredients
-
D&C Yellow No. 10,
dibutyl sebacate,
ethylcellulose (20 mPa.s),
FD&C Blue No. 1,
FD&C Red No. 40,
ferrosoferric oxide,
gelatin,
oleic acid,
povidone k30,
propylene glycol,
shellac,
silicon dioxide,
sodium lauryl sulfate,
corn starch,
sucrose,
magnesium silicate,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related Images for "N 943"
More about dextroamphetamine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 209 Reviews
- Drug class: CNS stimulants
- FDA Alerts (2)
Consumer resources
- Patient Information
- Dextroamphetamine (Advanced Reading)
- Dextroamphetamine Oral Solution
- Dextroamphetamine Tablets
- Dextroamphetamine Sustained-Release Capsules
- Other brands
- Dexedrine, Zenzedi, Dextrostat, ProCentra, Liquadd
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.